• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康个体和慢性丙型肝炎患者中肽疫苗诱导的HCV特异性CD8 + T细胞的功能和表型特征

Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.

作者信息

Schlaphoff Verena, Klade Christoph S, Jilma Bernd, Jelovcan Sandra B, Cornberg Markus, Tauber Erich, Manns Michael P, Wedemeyer Heiner

机构信息

Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg Str. 1, 30625 Hannover, Germany.

出版信息

Vaccine. 2007 Sep 17;25(37-38):6793-806. doi: 10.1016/j.vaccine.2007.06.026. Epub 2007 Jun 29.

DOI:10.1016/j.vaccine.2007.06.026
PMID:17686555
Abstract

Only very limited information on phenotype and function of vaccine-induced CD8+ T cells is available for humans. We investigated hepatitis C virus-specific CD8+ T cells after vaccination with the HCV peptide-vaccine IC41 which includes 5 MHC-class I and 3 MHC class-II-restricted epitopes. In healthy subjects, IC41 induced both HCV-specific central memory as well as effector CD8+ T cells which rapidly expanded upon antigen exposure in vitro. IFNgamma production was dependent on formulation of the synthetic peptides with the adjuvant poly-l-arginine. In chronic HCV patients, the frequency of HCV-specific CD8+ T cells increased after vaccination with a decline of CD45RA-positive effector memory cells in some but not all patients. Thus, this study suggests that HCV-specific memory cells can be induced by peptide vaccination and that a reversion of functional impaired phenotypes by therapeutic vaccination is possible in chronic HCV infection.

摘要

关于疫苗诱导的人类CD8+T细胞的表型和功能,目前仅有非常有限的信息。我们研究了接种丙型肝炎病毒(HCV)肽疫苗IC41后的HCV特异性CD8+T细胞,该疫苗包含5个MHC-I类和3个MHC-II类限制性表位。在健康受试者中,IC41诱导产生了HCV特异性中枢记忆细胞以及效应性CD8+T细胞,这些细胞在体外接触抗原后迅速扩增。γ干扰素的产生取决于合成肽与佐剂聚-L-精氨酸的配方。在慢性HCV患者中,接种疫苗后HCV特异性CD8+T细胞的频率增加,部分但并非所有患者的CD45RA阳性效应记忆细胞数量减少。因此,本研究表明肽疫苗接种可诱导HCV特异性记忆细胞,并且在慢性HCV感染中,通过治疗性疫苗接种有可能逆转功能受损的表型。

相似文献

1
Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.健康个体和慢性丙型肝炎患者中肽疫苗诱导的HCV特异性CD8 + T细胞的功能和表型特征
Vaccine. 2007 Sep 17;25(37-38):6793-806. doi: 10.1016/j.vaccine.2007.06.026. Epub 2007 Jun 29.
2
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.使用肽疫苗IC41对慢性丙型肝炎无应答患者进行治疗性疫苗接种。
Gastroenterology. 2008 May;134(5):1385-95. doi: 10.1053/j.gastro.2008.02.058. Epub 2008 Mar 4.
3
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.丙型肝炎病毒感染中CD4(+)和CD8(+) T细胞的差异反应性
Hepatology. 2001 Jan;33(1):267-76. doi: 10.1053/jhep.2001.21162.
4
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.治疗性疫苗IC41作为慢性丙型肝炎患者标准治疗的晚期附加治疗手段。
Vaccine. 2009 Aug 13;27(37):5142-51. doi: 10.1016/j.vaccine.2009.06.027. Epub 2009 Jun 24.
5
Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.新型肽基疫苗可有效启动小鼠肝脏中不依赖“辅助”的CD8 + T细胞反应。
Hepatology. 2004 Aug;40(2):300-9. doi: 10.1002/hep.20330.
6
Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.对丙型肝炎病毒特异性CD8 + T细胞上CD127和KLRG1表达的分析揭示了外周血和肝脏中存在不同的记忆性T细胞亚群。
J Virol. 2007 Jan;81(2):945-53. doi: 10.1128/JVI.01354-06. Epub 2006 Nov 1.
7
Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.急性丙型肝炎病毒感染中白细胞介素-7受体α链(CD127)表达缺失与病毒持续存在相关。
Hepatology. 2006 Nov;44(5):1098-109. doi: 10.1002/hep.21365.
8
Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.慢性丙型肝炎病毒感染期间肝内CD8 + T细胞功能衰竭。
Hepatology. 2005 Oct;42(4):828-37. doi: 10.1002/hep.20856.
9
Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C.急性丙型肝炎患者中丙型肝炎病毒特异性记忆CD8(+) T细胞扩增的可视化演示。
Hepatology. 2001 Jan;33(1):287-94. doi: 10.1053/jhep.2001.21164.
10
Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.使用HLA-A*2402肽四聚体分析日本慢性丙型肝炎患者的CD8阳性T细胞反应。
J Med Virol. 2003 May;70(1):51-61. doi: 10.1002/jmv.10349.

引用本文的文献

1
Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions.通过分析性治疗中断评估治疗性HIV疫苗的疗效。
J Int AIDS Soc. 2015 Nov 9;18(1):20497. doi: 10.7448/IAS.18.1.20497. eCollection 2015.
2
Proteome-wide screening reveals immunodominance in the CD8 T cell response against classical swine fever virus with antigen-specificity dependent on MHC class I haplotype expression.全蛋白质组筛选揭示了针对经典猪瘟病毒的CD8 T细胞反应中的免疫显性,其抗原特异性取决于MHC I类单倍型表达。
PLoS One. 2013 Dec 23;8(12):e84246. doi: 10.1371/journal.pone.0084246. eCollection 2013.
3
High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.
一种新型丙型肝炎病毒(HCV)疫苗候选物(MVA-HCV),基于表达近乎全长 HCV 基因组的改良安卡拉痘苗病毒,在小鼠体内诱导出高效、广谱、多功能且持久的 T 细胞免疫应答。
J Virol. 2013 Jul;87(13):7282-300. doi: 10.1128/JVI.03246-12. Epub 2013 Apr 17.
4
Development of Global Consensus Sequence and Analysis of Highly Conserved Domains of the HCV NS5B Prote in.丙型肝炎病毒NS5B蛋白全球共识序列的开发及高度保守结构域分析
Hepat Mon. 2012 Sep;12(9):e6142. doi: 10.5812/hepatmon.6142. Epub 2012 Sep 25.
5
Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.病毒感染导致编码交叉反应性致病表位的病毒失去抗病毒免疫。
PLoS Pathog. 2012;8(4):e1002633. doi: 10.1371/journal.ppat.1002633. Epub 2012 Apr 19.
6
Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected].丙型肝炎病毒 NS3/NS4A DNA 疫苗在恒河猴中诱导模拟人类免疫应答的多表位 T 细胞应答[校正]。
Mol Ther. 2012 Mar;20(3):669-78. doi: 10.1038/mt.2011.188. Epub 2011 Sep 27.
7
Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.细胞毒性T淋巴细胞的免疫反应及丙型肝炎病毒感染疫苗研发的可能性
J Biomed Biotechnol. 2010;2010:263810. doi: 10.1155/2010/263810. Epub 2010 May 20.
8
Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles.针对具有不同人类白细胞抗原-I-A类等位基因的丙型肝炎病毒感染患者的肽疫苗I期临床研究。
Cancer Sci. 2009 Oct;100(10):1935-42. doi: 10.1111/j.1349-7006.2009.01256.x. Epub 2009 Jun 23.
9
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.丙型肝炎病毒核心基因表达增强在DNA免疫中未增强核心特异性免疫反应:异源DNA初免、蛋白加强免疫方案的优势
Genet Vaccines Ther. 2009 Jun 8;7:7. doi: 10.1186/1479-0556-7-7.